News

Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

Ingram's talked to Dr. Marc Roth and Blake Buzard with Saint Luke's Hospital Center for Precision Oncology about the rapid pace of advances in precision medicine.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.